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AbstrACt
Objective To examine whether different lifetime patterns 
of cigarette smoking are associated with chronic 
widespread pain (CWP) and chronic regional pain (CRP) at 
age 68.
Design Prospective cohort study.
setting England, Scotland and Wales.
Participants Up to 2347 men and women from the 
Medical Research Council National Survey of Health and 
Development, who have been followed up since birth in 
1946 and provided sufficient information on cigarette 
smoking across adulthood to be classified as never 
smoker, predominantly non-smoker, predominantly smoker 
or lifelong smoker and pain assessment at age 68.
Primary outcome measures Pain was self-reported 
at age 68, and CWP was defined according to American 
College of Rheumatology criteria. Participants who 
reported having pain for ≥3 months but who did not meet 
the CWP definition were classified as having CRP; those 
who reported pain which had lasted for <3 months were 
classified as ‘other’ pain. No pain was the reference group.
results Findings from multinomial logistic regression 
models indicated that compared with never smokers, 
predominantly non-smokers, predominantly smokers and 
lifelong smokers all had an increased risk of CWP; relative 
risk ratios=1.70(95% CI 1.16 to 2.49); 2.10(95% CI 1.34 
to 3.28) and 1.88(95% CI 0.99 to 3.57), respectively, after 
adjusting for sex, own occupational class, educational 
level, body mass index, leisure time physical activity, 
alcohol intake, long-standing illness and symptoms of 
anxiety and depression. No association was observed 
between smoking history and CRP or other pain.
Conclusions These results suggest that exposure 
to cigarette smoking at any stage in adulthood was 
associated with higher risk of CWP in later adulthood; 
highlighting the ongoing importance of smoking prevention 
programmes. It also suggests that assessment of lifetime 
smoking behaviour may be more useful in identifying 
those at greater risk of CWP in later life than assessment 
of current smoking status.
IntrODuCtIOn 
Chronic pain is highly prevalent in older 
populations and has major adverse impacts 
on quality of life, well-being and activity 
participation.1–4 Identifying modifiable risk 
factors associated with pain may inform inter-
ventions to prevent and/or alleviate its conse-
quences in later life. Cigarette smoking is one 
of many modifiable behavioural risk factors 
that may play a role in the development and 
progression of chronic pain. While this risk 
factor has already been widely studied5 6 with 
most longitudinal studies reporting weak or 
null associations,7–10 the majority of these 
have been in populations younger than 65.
Moreover, even when studies have included 
older adults, these have usually only consid-
ered a single assessment of smoking status 
(either at baseline or at the current or 
most recent time point). This information 
has then been used to classify individuals 
as current, former or never smokers, or as 
ever or never smokers. This is unlikely to 
adequately capture the variability in lifetime 
exposure to smoking and its associated health 
risks due to changes in smoking behaviour 
across adulthood. Distinguishing people 
with different lifetime smoking histories and 
investigating differences in their health pros-
pects may be especially important in older 
adults; although the prevalence of smoking 
strengths and limitations of this study
 ► This study uses prospective data on smoking be-
haviour ascertained across adulthood (from age 20 
to 68) providing us with the opportunity to charac-
terise different lifetime patterns of smoking.
 ► This study distinguishes chronic widespread pain 
from regional pain and examines the risk of both.
 ► Chronic pain was assessed at a single time point so 
we were not able to establish temporality.
 ► Lifelong smokers were under-represented in the 
study sample as they had greater rates of all-cause 
mortality.
 ► Despite losses to follow-up over the 69 years of the 
study, the sample has remained broadly representa-
tive of the national population of England, Scotland 
and Wales born at a similar time.
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has steadily declined across all age groups over the last 
few decades, the baby boom generation who are currently 
reaching old age were at high risk of exposure to smoking 
earlier in adulthood.11 In addition, they are likely to have 
been exposed to antismoking campaigns and compre-
hensive tobacco control policies early enough in adult-
hood to have potentially benefited from the subsequent 
reductions in risk of smoking-related diseases linked to 
premature mortality.12 While people with some history 
of smoking are therefore now more likely to reach old 
age than they would have been in previous generations, 
whether they reach old age with more chronic conditions 
and symptoms such as pain remains to be established.
Using data from the Medical Research Council (MRC) 
National Survey of Health and Development (NSHD), 
which has assessed smoking status at multiple time 
points across adulthood, this paper aims to examine 
whether different lifetime patterns of cigarette smoking 
are associated with chronic widespread pain (CWP) and 
chronic regional pain (CRP) at age 68.
MethODs
study population
The MRC NSHD is a socially stratified population sample 
of 5362 single, legitimate births that occurred in England, 
Wales and Scotland in 1 week of March 1946. Participants 
have been prospectively followed from birth, and partic-
ipation rates have remained high.13–16 At the 24th data 
collection, conducted between 2014 and 2015 when study 
members were aged 68–69, study participants were first 
asked to complete a postal questionnaire at age 68 before 
then being invited to have a home visit by a research nurse 
at age 69.15 Of the 2816 people in the target sample living 
in England, Scotland and Wales, 2370 (84.2%) completed 
a postal questionnaire. In addition, a postal questionnaire 
was sent to 126 study members living abroad who remain 
in contact with the study of whom 83 (65.9%) returned 
a questionnaire. No attempt was made to contact the 
remaining 2420 study members: 957 (17.8%) had already 
died, 620 (11.6%) had previously withdrawn from the 
study, 448 (8.3%) had emigrated and were no longer in 
contact with the study and 395 (7.4%) had been untrace-
able for more than 5 years.
Patient and public involvement statement
Participants have a lifelong association with NSHD. Over 
the 72 years of the study, the research team has increas-
ingly involved participants, in line with changing norms 
about conducting cohort studies, starting at age 16 (in 
1962) with the annual dissemination of study findings in 
birthday cards. Participants receive personal letters when-
ever they raise queries or provide additional comments, 
including suggestions for new topics to study. In the 
last 10 years, the research team has increased the level 
of participant involvement through invitations to study 
events (65th and 70th birthday celebrations), public 
engagement activities and focus groups to discuss clinical 
substudies. When piloting new questionnaires and assess-
ments, we recruit patients from general practitioner prac-
tices or from the University College London Hospital 
patient public involvement group and take into account 
their feedback when designing the mainstage fieldwork.
Assessment of pain
Information on pain was ascertained in the postal ques-
tionnaire administered at age 68. Participants were asked 
whether they had experienced any ache or pain in the last 
month which had lasted for 1 day or longer, not including 
pain occurring during the course of a feverish illness such 
as influenza. Those who reported pain were then asked to 
report whether or not they had experienced this pain for 
at least 3 months and to shade the location of their pain 
using a four-view body manikin. Using American College 
of Rheumatology criteria,17 CWP was defined as pain 
present for 3 months or longer, both above and below 
the waist, on both the left and right side of the body and 
in the axial skeleton. Participants who reported having 
pain for at least 3 months but who did not meet the CWP 
definition were classified as having CRP and those who 
reported pain that had lasted for less than 3 months were 
classified as having ‘other’ pain.18
Assessment of smoking
Data on cigarette smoking were obtained on eight occa-
sions across adulthood using postal questionnaires (at 
ages 20, 25, 31, 60–64, 68–69) and nurse interviews (at 
ages 36, 43, 53). At each of these ages, study members 
were asked whether they currently smoked cigarettes. 
Participants who provided a negative response were 
asked whether they had ever smoked. This information 
was used to construct a set of variables indicating smoking 
status at each age from 20 to 68, coded as current, former 
and never smoker. Using these three-category variables, 
a lifetime smoking history variable was then constructed 
according to Clennell et al.19 Using this approach, we 
included those who provided smoking data for at least 
three waves and for whom missing data were not sequen-
tial at three or more waves (n=3705). Based on their 
reported smoking status at each age across adulthood, 
participants were grouped into one of four categories to 
summarise their smoking history: (1) participants who 
reported being non-smokers at all available data collec-
tions were classified as ‘never smokers’; (2) participants 
who reported being smokers at all available data collec-
tions were classified as ‘lifelong smokers’; participants 
who were classified as smokers at some ages and as ex 
or never smokers at other ages were classified as: (3) 
‘predominantly non-smoker’ if they were a non-smoker 
on at least three occasions and more often reported 
being a non-smoker than a smoker; (4) ‘predominantly 
smoker’ if they reported being a smoker on four or more 
occasions and more often reported being a smoker than 
a non-smoker. For example, if a study member reported 
being a smoker on five occasions and an ex-smoker on 
two occasions, they were classified as ‘predominantly 
3Bendayan R, et al. BMJ Open 2018;8:e021896. doi:10.1136/bmjopen-2018-021896
Open access
smoker’ whereas if they reported the reverse they were 
classified as ‘predominantly non-smoker’.19
Covariates
Potential confounders were selected a priori based 
on previous research on chronic pain and health 
behaviours.20–23 These were sex, socioeconomic position 
(indicated by own occupational class (which also allows us 
to distinguish between manual and non-manual work) and 
educational level), body mass index (BMI), other health 
behaviours (leisure time physical activity and alcohol 
intake), long-standing illness and symptoms of anxiety 
and depression. Unless otherwise specified these were 
assessed at age 68. Own occupation at age 53 years (or if 
not available, the most recent measure in adulthood) was 
categorised according to the Registrar General’s social 
classification into three groups: high (I (Professional) or 
II (Managerial and technical)); middle (IIINM (skilled 
non-manual (NM)) or IIIM (skilled manual (M))); low (IV 
(partly skilled manual) or V (unskilled manual)). Highest 
educational level achieved by age 26 was categorised into 
three groups: no qualifications; up to O-level or equiva-
lent; A-level or equivalent and above. BMI (kg/m2) was 
calculated from height (m) and weight (kg) measured by 
a trained nurse during the clinical assessment at age 69. 
Physical activity was assessed through self-reports of the 
level of participation in sports, vigorous leisure activities 
or exercise grouped as: inactive, moderately active (1–4 
times/month) or most active (5 times or more/month). 
Similarly, alcohol intake in the last year was self-reported 
as never, only on special occasions, monthly or less, 2–4 
times per month, 2–3 times per week, or 4 or more times 
per week. In addition, participants were asked whether 
they had any long-standing illness or health problems 
which had lasted, or were expected to last for 6 months or 
more. Symptoms of anxiety and depression were assessed 
using the 28-item General Health Questionnaire (GHQ-
28). Each GHQ-28 item was coded using the General 
Scoring Method (ie, 0 for response choices 1 and 2; and 
as 1 or response choices 3 and 4). Symptoms of anxiety 
and depression were indicated by summing responses to 
all items and applying a threshold for caseness of 5 or 
more.24
statistical analyses
Multinomial logistic regression models were used to 
examine the associations between lifetime smoking 
history and pain outcomes (with no pain as the reference 
category). Models were first adjusted for sex and formal 
tests of interaction between sex and lifetime smoking 
history were undertaken. As no evidence of interac-
tions with sex was found, subsequent models were sex 
adjusted. We then adjusted for each set of covariates in 
turn before adjusting for all covariates simultaneously in 
a final model. All models included the maximum number 
of participants with complete data on lifetime smoking 
history and pain (n=2347). To reduce data loss, covari-
ates with missing values (ie, educational attainment 
(n=114), occupational class (n=6), BMI (n=435), leisure 
time physical activity (n=25), alcohol intake (n=25), long-
standing illness or health problems (n=24) and GHQ-28 
(n=422) were imputed using multiple imputation by 
chained equations.25 Analyses were performed across 20 
imputed datasets and combined using Rubin’s rules. In 
sensitivity analyses, models were rerun on the sample with 
complete data on all covariates (n=1759). All analyses 
were conducted using STATA V.14.1.
results
Of the total analytical sample of 2347, 1304 (55.6%) 
reported pain, with 10.6% reporting CWP, 30.3% 
reporting CRP and 14.7% reporting ‘other pain’. More 
women than men reported CWP (13.2% for women 
vs 7.7% for men, p<0.001). Overall, the prevalence of 
smoking declined across adulthood from 55.8% for men 
and 46.8% of women at age 20 to 9.9% for men and 7.8% 
for women by age 68 (p values for sex differences at both 
ages <0.001) (online supplementary table 1). The prev-
alence of lifelong non-smokers was 34.3% for women 
and 26.3% for men. Of those classified as predominantly 
non-smokers, 61.6% had stopped smoking at least once 
by age 25 and only 0.5% were smokers at the most recent 
report. Of those classified as predominantly smokers, 
88.9% were smokers at age 25, but only 14.2% were still 
smokers at the most recent report. Descriptive statistics 
are shown in table 1. All covariates were associated with 
pain outcomes in the expected directions.
In sex-adjusted models, predominantly non-smokers, 
predominantly smokers and lifelong smokers all had 
a higher likelihood of CWP, compared with lifelong 
non-smokers (relative risk ratios (RRRs) of CWP vs no 
pain=1.80 (95% CI 1.26 to 2.58), 2.64 (95% CI 1.74 to 
3.99) and 2.27 (95% CI 1.25 to 4.13), respectively (table 2, 
model 1). Adjustment for each set of covariates had only 
limited impact and associations were maintained in 
fully adjusted models; RRRs 1.70 (95% CI 1.16 to 2.49) 
for predominantly non-smokers, 2.10 (95% CI 1.34 to 
3.28) for predominantly smokers and 1.88 (95% CI 0.99 
to 3.57) for lifelong smokers (table 2, model 6). No asso-
ciations were observed between lifetime smoking history 
and CRP or other pain (table 2).
When analyses were restricted to those with complete 
data (n=1759), we found similar results and the overall 
conclusions remained the same (online supplementary 
table 2).
DIsCussIOn
The main aim of this study was to examine whether 
different patterns of cigarette smoking over the life 
course were associated with CWP and CRP at age 68 in 
a nationally representative birth cohort. Our results 
showed that exposure to cigarette smoking at any time 
point across adulthood was associated with increased risk 
of CWP at age 68, even after adjustment for a range of 
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potential confounders and mediators. However, there 
was no evidence of associations between lifetime cigarette 
smoking and CRP or other pain.
Comparisons with other studies
Our finding of an association between different patterns 
of lifetime smoking and CWP in older adults builds on 
findings from other previous studies of chronic pain 
in older adults. For example, in a longitudinal study of 
British adults aged 50 years or older, individuals who 
were current smokers had higher odds of pain at base-
line but there was no evidence for increased likelihood of 
new-onset widespread pain over 3 years of follow-up when 
former and current smokers were combined in one group 
and compared with never smokers.23 Likewise, a cross-sec-
tional study found that smoking status was only associated 
with chronic pain prevalence when current and former 
smokers were combined in one group and compared with 
never smokers among people aged 65 years and older in 
Sweden.26 By using data collected prospectively across 
adulthood, we were able to distinguish different lifetime 
patterns of cigarette smoking and go beyond previous 
research. This has strengths when compared with other 
studies that have relied on single assessments of smoking 
and may therefore not adequately or reliably capture all 
relevant lifetime exposure.
Potential explanations of findings
Our finding of increased risk of CWP among all smoking 
groups (ie, predominantly non-smokers, predominantly 
smokers and lifelong smokers), when compared with 
never smokers suggests that cigarette smoking even for 
a short period of time over the life course may have a 
long-lasting impact on the probability of reporting CWP 
in later adulthood. One plausible explanation for this 
finding is that smoking may produce changes in central 
nervous system function that increase susceptibility to 
pain the effects of which continue to persist after smoking 
cessation.27 Another consideration is that the associa-
tions between smoking and pain may be bi-directional; 
not only is there evidence that tobacco smoking may be 
a risk factor for the development and exacerbation of 
pain but also that pain may serve to motivate smoking.7 
For this reason, it is possible that some individuals in our 
study may have developed CWP in early adulthood and 
Table 1 Characteristics of participants from the MRC 
National Survey of Health and Development by sex at age 
68 (maximum n=2347)
Men, N* (%) Women, N* (%) P values†
Total 1123 (47.9) 1224 (52.1)
Pain at age 68
  No pain 537 (47.8) 506 (41.3) <0.001
  Other pain 184 (16.4) 162 (13.2)
  Chronic regional 
pain
316 (28.1) 394 (32.2)
  Chronic 
widespread pain
86 (7.7) 162 (13.2)
Lifetime smoking history
  Never smoker 295 (26.3) 420 (34.3) <0.001
  Predominantly 
non-smoker
527 (46.9) 516 (42.2)
  Predominantly 
smoker
228 (20.3) 224 (18.3)
  Lifelong smoker 73 (6.5) 64 (5.2)
BMI (kg/m2) at age 69 (n=1919)
  Mean (SD) 28.0 (4.46) 28.1 (5.56) 0.92
Occupational class at age 53
  High (I/II) 631 (56.3) 458 (37.5) <0.001
  Middle (IIINM/
IIIM) 385 (34.4) 543 (44.5)
  Low (IV/V) 104 (9.3) 220 (18.0)
Educational attainment by age 26
  A-level or 
equivalent and 
above 505 (47.2) 374 (32.2)
<0.001
  Up to O-level or 
equivalent 212 (19.8) 419 (36.1)
  None 354 (33.1) 369 (31.8)
Alcohol intake at age 68
  Never 205 (18.5) 396 (32.7) <0.001
  Monthly or less 55 (5.0) 107 (8.8)
  2–4 times per 
month 157 (14.1) 203 (16.8)
  2–3 times per 
week
295 (26.6) 262 (21.6)
  ≥4 times per 
week
398 (35.9) 244 (20.1)
Participation in leisure time physical activity at age 68
  Most active (≥5 
times/month)
319 (28.7) 320 (26.4) 0.18
  Moderately 
active (1–4 
times/month)
123 (11.1) 161 (13.3)
  Inactive 669 (60.2) 730 (60.3)
Long-standing illness or health problem at age 68
  No 449 (40.3) 508 (42.0) 0.38
  Yes 666 (59.7) 700 (57.9)
Continued
Men, N* (%) Women, N* (%) P values†
Symptoms of anxiety and depression (GHQ-28) at age 68
  No (≤4) 840 (90.7) 829 (83.0) <0.001
  Yes (>4) 86 (9.3) 170 (17.0)
*Sample restricted to those participants with data on smoking 
history and pain. N varies due to missing data on covariates.
†Comparison of sexes using Student’s t-test or χ2 tests as 
appropriate.
BMI, body mass index; GHQ-28, 28-item General Health 
Questionnaire; MRC, Medical Research Council.
Table 1 Continued 
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used smoking as a coping strategy for this with this then 
causing them to experience greater difficulty quitting.28
Those associations were observed between lifetime 
smoking and CWP but not with CRP or other pain 
suggests that any influence of smoking on pain is likely 
to be operating via mechanisms related specifically to 
the development of CWP. This is consistent with the 
idea that CWP and CRP may have different underlying 
aetiologies.7 For example, some studies have suggested 
that nicotine may alter pain regulatory mechanisms (eg, 
potential alteration of pain processing or cause struc-
tural changes to other systems) which might have long-
term consequences for painful chronic conditions.29 The 
associations between lifetime smoking and CWP were 
only partially attenuated after adjustment for a range 
of factors including sex, socioeconomic position, body 
size, other health behaviour, long-standing illness and 
symptoms of anxiety and depression. This suggests that 
Table 2 Associations between lifetime smoking history and pain at age 68 (n=2347)
CWP versus no pain CRP versus no pain Other pain versus no pain
RRR (95% CI) P values RRR (95% CI) P values RRR (95% CI) P values
Model 1
  Never smoker 1 0.0001 1 0.25 1 0.25
  Predominantly non-smoker 1.80 (1.26 to 2.58) 1.08 (0.86 to 1.35) 1.14 (0.85 to 1.52)
  Predominantly smoker 2.64 (1.74 to 3.99) 1.32 (0.99 to 1.74) 1.44 (1.01 to 2.04)
  Lifelong smoker 2.27 (1.25 to 4.13) 0.97 (0.62 to 1.51) 1.05 (0.60 to 1.84)
Model 2
  Never smoker 1 <0.001 1 0.33 1 0.09
  Predominantly non-smoker 1.80 (1.26 to 2.59) 1.08 (0.86 to 1.35) 1.16 (0.87 to 1.55)
  Predominantly smoker 2.52 (1.65 to 3.84) 1.29 (0.97 to 1.71) 1.51 (1.06 to 2.17)
  Lifelong smoker 2.11 (1.15 to 3.86) 0.94 (0.60 to 1.47) 1.13 (0.64 to 1.99)
Model 3
  Never smoker 1 <0.001 1 0.46 1 0.17
  Predominantly non-smoker 1.85 (1.28 to 2.66) 1.06 (0.84 to 1.33) 1.09 (0.82 to 1.47)
  Predominantly smoker 2.43 (1.59 to 3.71) 1.22 (0.92 to 1.62) 1.37 (0.96 to 1.96)
  Lifelong smoker 2.12 (1.15 to 3.91) 0.95 (0.60 to 1.48) 1.12 (0.63 to 1.99)
Model 4
  Never smoker 1 <0.001 1 0.45 1 0.20
  Predominantly non-smoker 1.69 (1.17 to 2.45) 1.05 (0.83 to 1.31) 1.12 (0.84 to 1.50)
  Predominantly smoker 2.33 (1.52 to 3.58) 1.23 (0.93 to 1.64) 1.40 (0.98 to 2.00)
  Lifelong smoker 2.08 (1.12 to 3.86) 0.93 (0.59 to 1.46) 1.03 (0.59 to 1.81)
Model 5
  Never smoker 1 <0.001 1 0.37 1 0.20
  Predominantly non-smoker 1.77 (1.23 to 2.55) 1.07 (0.86 to 1.34) 1.13 (0.85 to 1.51)
  Predominantly smoker 2.47 (1.62 to 3.76) 1.27 (0.96 to 1.68) 1.40 (0.99 to 2.00)
  Lifelong smoker 2.13 (1.16 to 3.91) 0.93 (0.60 to 1.46) 1.02 (0.58 to 1.80)
Model 6
  Never smoker 1 0.002 1 0.90 1 0.15
  Predominantly non-smoker 1.70 (1.16 to 2.49) 1.01 (0.80 to 1.28) 1.10 (0.82 to 1.48)
  Predominantly smoker 2.10 (1.34 to 3.28) 1.12 (0.83 to 1.51) 1.39 (0.97 to 2.01)
  Lifelong smoker 1.88 (0.99 to 3.57) 0.87 (0.54 to 1.38) 1.15 (0.64 to 2.06)
Model adjustments:
1: sex.
2: sex and socio-economic position (education at age 26, own occupational class).
3: sex and other health behaviours (BMI, alcohol intake and physical activity).
4: sex and long-standing illness or health problems.
5: sex and symptoms of anxiety and depression (GHQ-28).
6: all covariates included in models 1 to 5.
BMI, body mass index; CRP, chronic regional pain; CWP, chronic widespread pain; GHQ-28, 28-item General Health Questionnaire; 
RRR, relative risk ratio.
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there might be other relevant explanatory variables. For 
example, although affective symptoms have been taken 
into consideration in our study some psychosocial models 
have highlighted the role of pain-related stress, fear or 
anxiety sensitivity in the transition from acute to chronic 
pain.7 30 31 These pain-specific measures were not available 
in our data, and therefore, future studies are encouraged 
to include these and examine their association with CWP 
onset and smoking.
Methodological considerations
One of the main strengths of our study was the use of 
data from a large nationally representative sample of 
older adults with prospective ascertainment of smoking 
status across adulthood which allowed us to characterise 
different lifetime patterns of smoking. Although we were 
unable to validate self-reports of smoking using cotinine 
measurements or reliably distinguish between light and 
heavy smokers, our approach does still have important 
strengths when compared with the commonly used cate-
gorisation of never, ex or current smoker based on self-re-
ported smoking at a single time point. While the use of 
recalled information on quitting attempts between assess-
ments could have introduced bias, when we performed 
sensitivity analyses to check for potential inconsistencies 
in reporting and compared results with retrospective 
measures on time since quitting for former smokers there 
were no differences in findings. However, the observed 
increase in prevalence of never smokers at older ages 
(online supplementary table 2) suggests that smokers 
were more likely than non-smokers to be lost to follow-up. 
This is partly explained by the fact that lifelong smokers 
had much greater rates of all-cause mortality across 
adulthood up to age 69 (online supplementary table 3); 
survival bias or differences in statistical power may there-
fore explain why predominantly smokers were found to 
have higher relative risks of CWP than lifelong smokers 
when both groups were compared with never smokers. 
However, another potential explanation of this finding 
which needs to be considered is the possibility that life-
long smokers may be less likely to experience CWP than 
predominantly smokers due to psychological or physio-
logical effects.
Another potential limitation of our analyses is that we 
cannot rule out reverse causation as chronic pain was 
only assessed at one time point. As noted above, recent 
research has highlighted that the association between 
smoking and pain is likely to be bidirectional28 32 and so 
future longitudinal studies with prospective ascertain-
ment of both smoking and pain across life should be 
performed. Such studies would also benefit from assess-
ment of pain severity and information on potential causes 
of pain, such as history of accident, which we were not 
able to take account of in our analyses but which may 
provide important additional insights. Although our find-
ings are generalisable to the current generation of adults 
reaching old age in the UK, changing trends in smoking 
behaviour over the last 70 years11 33 should be considered 
and further research is needed to examine whether 
similar associations will be observed in more recently 
born cohorts who will have experienced different selec-
tion effects into smoking and different lifetime patterns 
of exposure to smoking.
COnClusIOns
Our results highlight the role of smoking at any time point 
across adulthood as an independent risk factor for CWP 
in later adulthood, after considering socioeconomic, 
psychosocial and health-related factors. The evidence 
provided for the long-lasting effect of smoking on this 
condition highlights the potential benefit of considering 
smoking history rather than current smoking status when 
identifying those at greater risk of CWP in later life espe-
cially as opportunities to prevent CWP may be missed if 
only current smokers are classified as higher risk. These 
findings are relevant from a clinical and public health 
perspective, as smoking is a modifiable risk factor and our 
findings suggest that its primary prevention may be key.
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